|
TPM3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.99680272316982E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.03590033720502E-10 |
| Normal-vs-Stage2 |
6.41249999999705E-05 |
| Normal-vs-Stage3 |
1.1946000000318E-06 |
| Normal-vs-Stage4 |
2.12949999855994E-08 |
| Stage1-vs-Stage2 |
5.728200E-01 |
| Stage1-vs-Stage3 |
2.701400E-01 |
| Stage1-vs-Stage4 |
2.076800E-01 |
| Stage2-vs-Stage3 |
8.186800E-01 |
| Stage2-vs-Stage4 |
1.896840E-01 |
| Stage3-vs-Stage4 |
6.227700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.18980381103029E-11 |
| Normal-vs-AfricanAmerican |
3.843500E-04 |
| Normal-vs-Asian |
8.942100E-02 |
| Caucasian-vs-AfricanAmerican |
1.271830E-01 |
| Caucasian-vs-Asian |
5.992000E-01 |
| AfricanAmerican-vs-Asian |
2.750000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.37909716769036E-11 |
| Normal-vs-Female |
5.00170005413025E-09 |
| Male-vs-Female |
8.053600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.819100E-04 |
| Normal-vs-Age(41-60Yrs) |
7.67749974706078E-10 |
| Normal-vs-Age(61-80Yrs) |
5.46869993733878E-10 |
| Normal-vs-Age(81-100Yrs) |
6.191300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.572600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.236400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.303200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.941000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.083000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.336000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.89180000001554E-06 |
| Normal-vs-Grade 2 |
4.51039205984216E-12 |
| Normal-vs-Grade 3 |
1.05100000036273E-07 |
| Normal-vs-Grade 4 |
3.20529999997543E-06 |
| Grade 1-vs-Grade 2 |
2.446400E-01 |
| Grade 1-vs-Grade 3 |
7.596100E-02 |
| Grade 1-vs-Grade 4 |
4.170600E-01 |
| Grade 2-vs-Grade 3 |
4.742300E-02 |
| Grade 2-vs-Grade 4 |
6.887400E-01 |
| Grade 3-vs-Grade 4 |
1.749250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.72006853205176E-12 |
| Normal-vs-ccB subtype |
1.24109999999344E-06 |
| ccA subtype-vs-ccB subtype |
1.322570E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.46590003971647E-09 |
| Normal-vs-N1 |
2.135500E-03 |
| N0-vs-N1 |
6.086300E-02 |
|
|
